摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-epidithio-1,3,4,6-tetramethyl-2,5-dioxopiperazine | 53338-36-6

中文名称
——
中文别名
——
英文名称
3,6-epidithio-1,3,4,6-tetramethyl-2,5-dioxopiperazine
英文别名
1,4,5,7-tetramethyl-2,3-dithia-5,7-diazabicyclo[2.2.2]octane-6,8-dione
3,6-epidithio-1,3,4,6-tetramethyl-2,5-dioxopiperazine化学式
CAS
53338-36-6
化学式
C8H12N2O2S2
mdl
——
分子量
232.327
InChiKey
JNACNFRANQECFU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    91.2
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2934999090

SDS

SDS:e11e769f5b2d2a2ff883bab9e55a9e2b
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Thiolation of symmetrical and unsymmetrical diketopiperazines
    作者:Bettina M. Ruff、Sabilla Zhong、Martin Nieger、Stefan Bräse
    DOI:10.1039/c2ob06663g
    日期:——
    The introduction of sulfur units into a variety of symmetrical and unsymmetrical diketopiperazines (DKPs) is described. We investigated different thiolation methods utilizing several bases and electrophilic sulfur reagents, leading to monomethylthio-, bis(methylthio)-, and epithio-DKPs. Their formation proceeded diastereoselectively, facilitating the application in total syntheses of many thiodiketopiperazine (TDKP) natural products. Furthermore, possible side reactions as well as mechanistic studies and stereochemical structural assignments of the obtained products are given.
    本文介绍了将硫单元引入各种对称和不对称二酮哌嗪(DKPs)的方法。我们利用几种碱和亲电硫试剂研究了不同的硫代方法,从而得到了单甲硫基、双(甲硫基)和表硫基 DKPs。它们的形成是非对映选择性的,有利于应用于许多硫代二酮哌嗪(TDKP)天然产物的全合成。此外,还给出了可能的副反应以及所获产物的机理研究和立体化学结构分配。
  • Synthesis of sulfur-bridged piperazinediones by reaction of 3,6-dibromo-1,4-dimethyl-2,5-piperazinedione with<i>geminal</i>dithiols
    作者:Ananthachari Srinivasan、Aldean J. Kolar、Richard K. Olsen
    DOI:10.1002/jhet.5570180811
    日期:1981.12
    the 3,6-position with a geminal dithiol-bridging group. These sulfur-bridged piperazinediones formally represent derivatives of the 2,4-dithia-6,8-diaza-7,9-dioxobicyclo[3.2.2]nonane ring system. Attempts to transform these sulfur-bridged piperazinediones to 3,6-epidithiopiperazinediones by removal of the bridging group common to the sulfur functionality were unsuccessful. Studies also are reported of
    几个反应偕二硫醇与3,6-二溴-1,4-二甲基-2,5-哌嗪二酮在3,6-位被取代的良好的产率哌嗪衍生物,得到偕二硫醇桥接基团。这些硫桥联哌嗪二酮正式代表2,4-二硫-6,8-二氮杂-7,9-二氧代双环[3.2.2]壬烷环系统的衍生物。通过除去硫官能团共有的桥连基团,尝试将这些硫桥连的哌嗪二酮转化为3,6-表二硫代哌嗪二酮是不成功的。还报道了将硫代乙酸加到3,6-二亚甲基-2,5-哌嗪二酮中得到3,6-二乙酰硫基-3,6-二甲基-2,5-哌嗪二酮的研究。将3,6-二乙酰硫基衍生物转化为表硫基哌嗪二酮环系统,得到表二硫代哌嗪和表二硫代哌嗪二酮的混合物。
  • EPIDITHIODIOXOPIPERAZINE COMPOUND OR ITS DERIVATIVES, AND THE USE THEREOF
    申请人:EWHA University-Industry Collaboration Foundation
    公开号:US20160222031A1
    公开(公告)日:2016-08-04
    The present invention relates to an epidithiodioxopiperazine derivative represented by the following Chemical Formula 1 or its reduced derivative; a method for preparing a compound represented by Chemical Formula 1 having improved intracellular permeability and mimicking the activity of 2-Cys-Prx in its reduced form in the cells; a pharmaceutical composition for preventing or treating vascular diseases comprising an epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient; a drug delivery device for local administration including the pharmaceutical composition; and a pharmaceutical composition for inhibiting melanoma metastasis comprising the epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient.
    本发明涉及以下化学式1所表示的表皮二硫二氧哌嗪衍生物或其还原衍生物;一种制备化学式1所表示的化合物的方法,该方法具有改善细胞内渗透性并在其还原形式下模拟2-Cys-Prx在细胞中的活性;一种预防或治疗血管疾病的制药组合物,包括表皮二硫二氧哌嗪化合物或其衍生物或其药学上可接受的盐作为活性成分;一种用于局部给药的药物递送装置,包括该制药组合物;以及一种抑制黑色素瘤转移的制药组合物,包括表皮二硫二氧哌嗪化合物或其衍生物或其药学上可接受的盐作为活性成分。
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SOLID CANCER, CONTAINING EPIDITHIODIOXOPIPERAZINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    申请人:VASTHERA Co. Ltd.
    公开号:EP4023224A1
    公开(公告)日:2022-07-06
    The present invention relates to a pharmaceutical composition for prevention or treatment of solid cancer comprising an epidithiodioxopiperazine derivative compound based on a parent structure comprising an intramolecular disulfide bridge in an epidithiodioxopiperazine ring or a pharmaceutically acceptable salt thereof as an active ingredient.
    本发明涉及一种用于预防或治疗实体瘤的药物组合物,该组合物包含一种基于母体结构的表二硫代二氧哌嗪衍生物化合物,该母体结构包含表二硫代二氧哌嗪环中的分子内二硫桥或其药学上可接受的盐作为活性成分。
  • Epidithiodioxopiperazine compound or its derivatives, and the use thereof
    申请人:VASTHERA Co. Ltd.
    公开号:US10450327B2
    公开(公告)日:2019-10-22
    The present invention relates to an epidithiodioxopiperazine derivative represented by the following Chemical Formula 1 or its reduced derivative; a method for preparing a compound represented by Chemical Formula 1 having improved intracellular permeability and mimicking the activity of 2-Cys-Prx in its reduced form in the cells; a pharmaceutical composition for preventing or treating vascular diseases comprising an epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient; a drug delivery device for local administration including the pharmaceutical composition; and a pharmaceutical composition for inhibiting melanoma metastasis comprising the epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient.
    本发明涉及一种由以下化学式1代表的表二硫代二酮哌嗪衍生物或其还原衍生物;一种制备由化学式1代表的化合物的方法,该化合物具有更好的细胞内渗透性,并能模拟细胞内还原形式的2-Cys-Prx的活性;一种用于预防或治疗血管疾病的药物组合物,其活性成分包括表二硫基二氧代哌嗪化合物或其衍生物或其药学上可接受的盐类;一种用于局部给药的给药装置,其活性成分包括该药物组合物;以及一种用于抑制黑色素瘤转移的药物组合物,其活性成分包括表二硫基二氧代哌嗪化合物或其衍生物或其药学上可接受的盐类。
查看更多